Logo

Lynx Announces New Head of Board of Directors

Jan 05, 2001

NEW YORK, Jan 5 – Lynx Therapeutics announced Friday that Craig Taylor has been named chairman of its board of directors.

Taylor, who has been director of Lynx since March 1994, will take over from Sam Eletr. Eletr is is leaving the board but is expected to stay on as a consultant to the company.

Taylor is president of Alloy Ventures, a venture capital firm that focuses on healthcare and information technology.

He is also a director of biotechnology company Pharmacyclics and a member of the board of directors of the National Venture Capital Association. He serves on the board of advisors of the MIT/Stanford Venture Laboratory.

Lynx of Hayward, Calif., develops Megaclone, a cloning procedure designed to discover gene expression patterns and genomic variations.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.